Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Lactobacillus for Urinary Symptoms in Neurogenic Bladder
NCT04323735Phase 2Active, not recruiting
- Sponsor
- MedStar Health Research Institute
- Start
- Jan 2020
- Primary completion
- Sep 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Lactobacillus rhamnosus GG in neurogenic bladder, sponsored by MedStar Health Research Institute. Started Jan 2020; status: active, not recruiting.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on NCT04323735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04323735.